welcomes you to the new, improved website!This study from the Canadian Ross Registry evaluated 466 consecutive patients who underwent a Ross procedure using a decellularized cryopreserved pulmonary homograft and evaluated for pulmonary homograft dysfunction. They demonstrate that the cumulative incidence of pulmonary homograft dysfunction was 11% at 6 years with pulmonary homograft stenosis (93%) being the most frequent cause, with an incidence of homograft reintervention of 3% at 6 years.
You are here:
Pulmonary homograft dysfunction after the Ross procedure using decellularized homografts—a multicenter study
Source: Journal of Thoracic and Cardiovascular Surgery
Keywords:
Author(s): Vincent Chauvette, MD, Ismail Bouhout, MD, Mohammed Tarabzoni, MD, Magali Pham, MD, Daniel Wong, MD, Richard Whitlock, MD, PhD, Michael W.A. Chu, MD, MSc, Ismail El-Hamamsy, MD, PhD, on behalf of the Canadian Ross Registry
